Lv2
140 积分 2025-07-15 加入
TITE-STEIN: Time-to-event simple toxicity and efficacy interval design to accelerate phase I/II trials
2个月前
已完结
A Bayesian phase I–II clinical trial design to find the biological optimal dose on drug combination
3个月前
已完结
COMIC: A Bayesian Dose Optimization Design for Drug Combination in Multiple Indications With Application to CAR‐T Therapies
3个月前
已完结
Progress in the application of artificial intelligence in molecular generation models based on protein structure
3个月前
已完结
DEMO: Dose exploration, monitoring, and optimization using biological and clinical outcomes
4个月前
已关闭
A Bayesian optimal interval design for dose optimization with a randomization scheme based on pharmacokinetics outcomes in oncology
4个月前
已完结
Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination Trials
10个月前
已完结
Modularity and innovation in knowledge-intensive business services: IT outsourcing in Germany and the UK
10个月前
已采纳
QTL Mapping of Yield and Yield Components for Elite Hybrid Derived-RILs in Upland Cotton
10个月前
已采纳
Tumor size, but not consolidation‐to‐tumor ratio, is an independent prognostic factor for part‐solid clinical T1 non‐small cell lung cancer
10个月前
已采纳
Sustainability‐Oriented Businesses and Earnings Management. What Is the True Relationship? Evidence From Italian Benefit Corporations
10个月前
已采纳
Nano‐Micro Engineering Modulating High‐Entropy Multilayer Ceramic Capacitor for High‐Performance Energy Storage
10个月前
已采纳
Influence of Functionality and Aromatic Content of Polyester Polyol on Rigid Polyurethane Foam Properties
10个月前
已采纳
Dissolvable microneedles based on active components of Chinese Herbal Medicine for enhanced treatment of skin diseases
10个月前
已采纳
Nanofluid thermoelectric cooler based advanced battery thermal management system for battery degradation mitigation in real driving cycles
10个月前
已采纳
A Streamflow Permanence Classification Model for Forested Streams That Explicitly Accounts for Uncertainty and Extrapolation
10个月前
已采纳
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
10个月前
已采纳
皖公网安备34019202002308
